{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T22:14:41Z","timestamp":1769897681255,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bjid.2025.104603","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T13:18:17Z","timestamp":1765977497000},"page":"104603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tenofovir vs. entecavir in chronic hepatitis B: A retrospective cohort study of hepatocellular carcinoma risk in a tertiary hospital in southern Brazil"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8863-5515","authenticated-orcid":false,"given":"Adriana Neis","family":"Stamm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7932-5937","authenticated-orcid":false,"given":"Cristiane Valle","family":"Tovo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3200-727X","authenticated-orcid":false,"given":"Andressa","family":"Noal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0054-3392","authenticated-orcid":false,"given":"Camila Ubirajara","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4441-0138","authenticated-orcid":false,"given":"Jaysa","family":"Pizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3050-4202","authenticated-orcid":false,"given":"Pedro Moreno","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4326-0024","authenticated-orcid":false,"given":"Dimas Alexandre","family":"Kliemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2025.104603_bib0001","series-title":"Global Hepatitis Report 2017","year":"2017"},{"key":"10.1016\/j.bjid.2025.104603_bib0002","doi-asserted-by":"crossref","DOI":"10.1590\/1980-549720220004","article-title":"Mortality due to hepatocellular carcinoma associated with hepatitis B and C viruses in the state of S\u00e3o Paulo, Brazil","volume":"25","author":"Cavalcante","year":"2022","journal-title":"Rev Bras Epidemiol."},{"key":"10.1016\/j.bjid.2025.104603_bib0003","series-title":"Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas De Hepatite B e coinfec\u00e7\u00f5es [recurso eletr\u00f4nico]","first-page":"144","article-title":"Minist\u00e9rio da sa\u00fade. secretaria de ci\u00eancia, tecnologia, inova\u00e7\u00e3o e complexo da sa\u00fade; secretaria de vigil\u00e2ncia em sa\u00fade e ambiente","year":"2023"},{"key":"10.1016\/j.bjid.2025.104603_bib0004","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.bjid.2025.104603_bib0005","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.bjid.2025.104603_bib0006","first-page":"3882","article-title":"Comparison of incidence of hepatocellular carcinoma between chronic hepatitis B patients with cirrhosis treated with entecavir or tenofovir in Taiwan: a retrospective study","volume":"10","author":"Chen","year":"2020","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.bjid.2025.104603_bib0007","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00432-025-06082-4","article-title":"Comparison of tenofovir versus entecavir for preventing hepatocellular carcinoma in chronic hepatitis B patients: an umbrella review and meta-analysis","volume":"151","author":"Liu","year":"2025","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.bjid.2025.104603_bib0008","first-page":"201","article-title":"Risk of hepatocellular carcinoma in treatment-na\u00efve chronic hepatitis B patients receiving tenofovir disoproxil fumarate versus entecavir in the United States","volume":"56","author":"Kim","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bjid.2025.104603_bib0009","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jamaoncol.2018.4070","article-title":"Risk of hepatocellular carcinoma in patients treated with entecavir vs tenofovir for chronic hepatitis B: a Korean nationwide cohort study","volume":"5","author":"Choi","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.bjid.2025.104603_bib0010","first-page":"55","article-title":"Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir vs entecavir-based regimens: individual patient data meta-analysis","volume":"79","author":"Choi","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.bjid.2025.104603_bib0011","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jhep.2019.03.028","article-title":"A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naive chronic hepatitis B in South Korea","volume":"71","author":"Kim","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.bjid.2025.104603_bib0012","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S2468-1253(20)30249-1","article-title":"Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis","volume":"5","author":"Tseng","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.bjid.2025.104603_bib0013","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000518940","article-title":"Tenofovir is superior to entecavir on tertiary prevention for BCLC stage A hepatocellular carcinoma after curative resection","volume":"11","author":"Tsai","year":"2021","journal-title":"Liver Cancer"},{"key":"10.1016\/j.bjid.2025.104603_bib0014","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1159\/000507253","article-title":"Tenofovir treatment has lower risk of hepatocellular carcinoma than entecavir treatment in patients with chronic hepatitis B: a systematic review and meta-analysis","volume":"9","author":"Liu","year":"2020","journal-title":"Liver Cancer"},{"key":"10.1016\/j.bjid.2025.104603_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2020.05.008","article-title":"Effects of tenofovir vs entecavir on risk of hepatocellular carcinoma in patients with chronic HBV infection: a systematic review and meta-analysis","volume":"19","author":"Choi","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bjid.2025.104603_bib0016","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1111\/jgh.15036","article-title":"Comparison of tenofovir versus entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: a systematic review and meta-analysis","volume":"35","author":"Gu","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.bjid.2025.104603_bib0017","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/jgh.15783","article-title":"Lower risk of hepatocellular carcinoma with tenofovir than entecavir treatment in subsets of chronic hepatitis B patients: an updated meta-analysis","volume":"37","author":"Yuan","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.bjid.2025.104603_bib0018","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/s41598-020-80523-7","article-title":"Long-term risk of primary liver cancers in entecavir versus tenofovir treatment for chronic hepatitis B","volume":"11","author":"Chang","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.bjid.2025.104603_bib0019","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jhep.2015.11.035","article-title":"PAGE-B predicts the risk of hepatocellular carcinoma in caucasian patients with chronic hepatitis B on 5-year antiviral therapy","volume":"64","author":"Papatheodoridis","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.bjid.2025.104603_bib0020","first-page":"712","article-title":"Similar 5-year hepatocellular carcinoma occurrence in tenofovir- vs entecavir-treated chronic hepatitis B patients: results from the French ANRS CO22 Hepather cohort","volume":"54","author":"Pol","year":"2021","journal-title":"Aliment Pharmacol Ther"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867025001047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867025001047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T07:23:53Z","timestamp":1769844233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867025001047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1413867025001047"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2025.104603","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tenofovir vs. entecavir in chronic hepatitis B: A retrospective cohort study of hepatocellular carcinoma risk in a tertiary hospital in southern Brazil","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2025.104603","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedade Brasileira de Infectologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"104603"}}